Evidence map›Paper›PMID 31698456›Full record

ArticleBlood advances2019

Associations between hematology/oncology fellows' training and mentorship experiences and hematology-only career plans.

Leah E Masselink, Clese E Erikson, Nathan T Connell, Laura M De Castro, Georgette A Dent, Ariela L Marshall, Rakhi P Naik, Marquita Nelson, Casey L O'Connell, Anita Rajasekhar and 3 more

Abstract read
In one paragraph

Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Hematology-Oncology Fellows' Use of Artificial Intelligence: A Multicenter Educational Practice and Needs Assessment Survey.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Research opportunities in Classical Hematology.Hematology, transfusion and cell therapy · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Putting the Heme Back in Heme-Onc: an Evaluation of the Redesigned Hematology Track within the Dana Farber/Mass General Brigham Hematology-Oncology Fellowship.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Leah E MasselinkDepartment of Health Policy and Management, Milken Institute School of Public Health, and.
Clese E EriksonFitzhugh Mullan Institute for Health Workforce Equity, The George Washington University, Washington, DC.
Nathan T ConnellHematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Laura M De CastroDivision of Hematology/Oncology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA.
Georgette A DentDepartment of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
Ariela L MarshallDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Rakhi P NaikDivision of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD.
Marquita NelsonSection of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL.
Casey L O'ConnellJane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Anita RajasekharDivision of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL.
Deva SharmaTransfusion Medicine Fellowship Program, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Melody SmithAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY; and.
Alfred Ian LeeSection of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
BASIC RESEARCH TRAINING IN MEDICAL ONCOLOGYT32CA009566 · NCI · UNIVERSITY OF CHICAGO · PI OLUFUNMILAYO F. OLOPADE · 1987 to 2026
$10.5M
NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA009566
6 · The paper itself

Abstract

As the adult hematology and oncology fellowship training pathways have merged in the United States and concerns have arisen about the aging of practicing hematologists, the American Society of Hematology and hematology education leaders are looking to improve their understanding of the factors that contribute to fellows' plans to enter hematology-only careers. With the support of the American Society of Hematology, we collected and analyzed data from a survey of hematology/oncology fellows (n = 626) to examine the relationship between training and mentorship experiences and fellows' plans to enter hematology-only careers. Fellows who planned to enter hematology-only careers were significantly more likely to report having clinical training and mentorship experiences in hematology throughout their training relative to fellows with oncology-only or combined hematology/oncology career plans. After controlling for prior interest in hematology and demographic characteristics, exposure to hematology patients in medical school and fellowship, hematology research experiences, and hematology mentorship (research collaboration and career coaching) were positively and significantly associated with hematology-only career plans. These findings suggest that increasing opportunities for exposure to hematology patients, research opportunities and mentors throughout training could be helpful in building a strong pipeline of potential hematologists.

Indexed as

Career ChoiceFellowships and ScholarshipsMentorsHematologyHumansLogistic ModelsMedical OncologySurveys and Questionnaires

Identifiers

PMID31698456
PMCPMC6855099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.